BIVI Stock Analysis: Buy, Sell, or Hold?
BIVI - BioVie, Inc. Common Stock
$1.58
-0.01 (-0.63%)
▼
5d:
+0.0%
30d:
+16.18%
90d:
+30.58%
BUY
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 11, 2026
11d
Get Alerted When BIVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BIVI shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: BIVI shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BIVI is currently trading at $1.58, which is considered extended relative to its 30-day fair value range of $1.35 to $1.53.
Technical Outlook: Technically, BIVI is in a uptrend. Immediate support is located at $1.35, while resistance sits at $1.72.
Market Sentiment: BIVI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+659.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BIVI is in a uptrend. Immediate support is located at $1.35, while resistance sits at $1.72.
Market Sentiment: BIVI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+659.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.35 -
$1.53
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 659.5% below Wall St target ($12.00)
Trading Range Analysis
30-Day Trading Range
$1.35 -
$1.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.35
Resistance Level
$1.72
Current Trend
Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Wall Street Target
$12.00
(+659.5%)
Share & Embed Analysis
Last updated: April 29, 2026 2:43 AM ET
Data refreshes hourly during market hours. Next update: 3:43 AM
Data refreshes hourly during market hours. Next update: 3:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIVI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 53 HOLD |
